Data management

SCOPE 2019

Solving pharma’s ‘big text’ problem with NLP

21-Feb-2019 By Maggie Lynch

There are about 27m articles in PubMed and 280,000 studies on ClinicalTrials.gov – so how does the industry begin to make sense of all this data?

‘Just a few mouse clicks’: TriNetX offers RWD analytics

21-Feb-2019 By Maggie Lynch

Global health research network, TriNetX, has added an analytic self-service offering for simplified analysis of real-world data.

PPD signs exclusive agreement with China-based AI company

21-Feb-2019 By Melissa Fassbender

PPD’s agreement with China-based Happy Life Tech focuses on site selection, patient recruitment, and real-world evidence generation for customers globally.

‘The magic balance’: Diverse advisory boards guide clinical trial design

20-Feb-2019 By Maggie Lynch

With the recent marriage between technology and science aimed at innovating aspects of clinical trials panels composed of experts from fields outside of pharma could prove to be impactful.

AI threatens health data privacy: Report

19-Feb-2019 By Melissa Fassbender

Artificial intelligence advances threaten data privacy, according to a new study, which found it is possible to re-identify individuals using their physical activity data.

SCOPE 2019

Oracle integrates Quorum IRB tech to smooth submission process

19-Feb-2019 By Melissa Fassbender

The collaboration between Quorum Review IRB and Oracle goBalto removes the need to send IRB submission documents manually.

SCOPE 2019

Shimmer shines with a new wearable platform for clinical trials

19-Feb-2019 By Melissa Fassbender

Shimmer designed its new Verisense platform from the ground up after finding that current activity trackers fail to meet the “basic needs of the clinical research market,” says company executive.

EMA implored to improve trial reporting, with over 50% of trials still missing results

18-Feb-2019 By Melissa Fassbender

The EMA needs to fix problems with the clinical trial registry to improve reporting across Europe, says TranspariMED founder, as seemingly small issues can “seriously hinder compliance.”

SCOPE 2019

Tech is advancing, but uncertainty creates an ‘opposing effect’ to positive movement

18-Feb-2019 By Melissa Fassbender

The industry has advanced to a point that should justify the financial investment in new technology, though uncertainty, and a lack of support, are hindering movement.

SCOPE 2019

Saama adds new AI-based capabilities to its analytics platform

18-Feb-2019 By Melissa Fassbender

Saama Technologies today unveiled three new machine learning-based capabilities, extending the functionality of its life science analytics cloud.

‘Couldn’t do it without technology’: Embracing clinical software for trial recruitment

15-Feb-2019 By Maggie Lynch

Getting patients into possibly life-saving trials has long been a complex process, however, with the age of electronic health records and cloud-based data, there are opportunities for simplification.

Boehringer Ingelheim and IBM bring blockchain to clinical trials

14-Feb-2019 By Maggie Lynch

Boehringer Ingelheim and IBM Canada are using blockchain technology for the first time in a clinical trial setting to test the technology’s trial management capabilities.

Innovaderm continues use of Medrio’s EDC for dermatology trials

14-Feb-2019 By Maggie Lynch

Innovaderm inks deal to extend its use of Medrio’s cloud-based EDC technology for early-phase dermatology clinical trials through 2023.

Smart Health Record allows patients to directly share their data

14-Feb-2019 By Melissa Fassbender

monARC Bionetworks’ Smart Health Record allows patients to directly share with researchers their data from various disparate sources – “creating a new data collaboration economy.”

Update

Iqvia quietly purchased UK-based NLP provider Linguamatics

12-Feb-2019 By Melissa Fassbender

Iqvia acquired UK-based Linguamatics in January 2019 as part of the company's commitment to deliver value from artificial intelligence and machine learning.